Global Blood Purification Equipment Market Size, Share, Trends & Growth Analysis Report 2026-2034

Description

The Blood Purification Equipment Market size is expected to reach USD 36.33 Billion in 2034 from USD 18.16 Billion (2025) growing at a CAGR of 8.01% during 2026-2034.

The global blood purification equipment market is growing steadily due to the increasing prevalence of kidney disorders and other chronic diseases. Blood purification devices are used to remove toxins and waste products from the blood when the body's natural filtration systems are not functioning properly. These devices are commonly used in treatments such as dialysis and hemoperfusion.

Several factors are driving the growth of this market. Rising cases of chronic kidney disease and other metabolic disorders are increasing the demand for blood purification treatments. In addition, aging populations and growing awareness about early diagnosis and treatment are encouraging the use of advanced medical equipment. Technological improvements in dialysis machines and filtration systems are also supporting market expansion.

The future outlook for the blood purification equipment market appears positive as healthcare systems continue to improve treatment options for chronic diseases. Advances in medical technology are expected to enhance treatment efficiency and patient comfort. As the demand for life-saving medical treatments increases, blood purification equipment will remain essential in modern healthcare.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Type

Dialysis
CRRT
Hemoperfusion
Others

By Product Type

Portable
Stationary

By Application

Sepsis
COVID-19
Infectious Diseases
Acute Kidney Injury
Others

By End-User

Hospitals & Clinics
Dialysis Centers
Others

COMPANIES PROFILED

CytoSorbents Corporation, Baxter International Inc, ExThera Medical Corporation, Aethlon Medical Inc, Fresenius SE Co KGaA, Cerus Corporation, Jafron Biomedical Co Ltd, Spectra Medical Inc, B Braun Melsungen AG, Nikkiso Co Ltd
We can customise the report as per your requirements.

Product Code: VMR11212859

Chapter 1. PREFACE

1.1. Market Segmentation & Scope
1.2. Market Definition
1.3. Information Procurement
- 1.3.1 Information Analysis
- 1.3.2 Market Formulation & Data Visualization
- 1.3.3 Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

2.1. Market Snapshot
2.2. Segmental Outlook
2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

3.1. Market Lineage Outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Value Chain Analysis
3.4. Regulatory Framework
- 3.4.1 Standards & Compliance
- 3.4.2 Regulatory Impact Analysis
3.5. Market Dynamics
- 3.5.1 Market Drivers
- 3.5.2 Market Restraints
- 3.5.3 Market Opportunities
- 3.5.4 Market Challenges
3.6. Porter's Five Forces Analysis
3.7. PESTLE Analysis

Chapter 4. GLOBAL BLOOD PURIFICATION EQUIPMENT MARKET: BY TYPE 2022-2034 (USD MN)

4.1. Market Analysis, Insights and Forecast Type
4.2. Dialysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.3. CRRT Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.4. Hemoperfusion Estimates and Forecasts By Regions 2022-2034 (USD MN)
4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BLOOD PURIFICATION EQUIPMENT MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

5.1. Market Analysis, Insights and Forecast Product Type
5.2. Portable Estimates and Forecasts By Regions 2022-2034 (USD MN)
5.3. Stationary Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BLOOD PURIFICATION EQUIPMENT MARKET: BY APPLICATION 2022-2034 (USD MN)

6.1. Market Analysis, Insights and Forecast Application
6.2. Sepsis Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.3. COVID-19 Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.4. Infectious Diseases Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.5. Acute Kidney Injury Estimates and Forecasts By Regions 2022-2034 (USD MN)
6.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BLOOD PURIFICATION EQUIPMENT MARKET: BY END-USER 2022-2034 (USD MN)

7.1. Market Analysis, Insights and Forecast End-user
7.2. Hospitals & Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.3. Dialysis Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
7.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL BLOOD PURIFICATION EQUIPMENT MARKET: BY REGION 2022-2034(USD MN)

8.1. Regional Outlook
8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.2.1 By Type
- 8.2.2 By Product Type
- 8.2.3 By Application
- 8.2.4 By End-user
- 8.2.5 United States
- 8.2.6 Canada
- 8.2.7 Mexico
8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.3.1 By Type
- 8.3.2 By Product Type
- 8.3.3 By Application
- 8.3.4 By End-user
- 8.3.5 United Kingdom
- 8.3.6 France
- 8.3.7 Germany
- 8.3.8 Italy
- 8.3.9 Russia
- 8.3.10 Rest Of Europe
8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.4.1 By Type
- 8.4.2 By Product Type
- 8.4.3 By Application
- 8.4.4 By End-user
- 8.4.5 India
- 8.4.6 Japan
- 8.4.7 South Korea
- 8.4.8 Australia
- 8.4.9 South East Asia
- 8.4.10 Rest Of Asia Pacific
8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.5.1 By Type
- 8.5.2 By Product Type
- 8.5.3 By Application
- 8.5.4 By End-user
- 8.5.5 Brazil
- 8.5.6 Argentina
- 8.5.7 Peru
- 8.5.8 Chile
- 8.5.9 South East Asia
- 8.5.10 Rest of Latin America
8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
- 8.6.1 By Type
- 8.6.2 By Product Type
- 8.6.3 By Application
- 8.6.4 By End-user
- 8.6.5 Saudi Arabia
- 8.6.6 UAE
- 8.6.7 Israel
- 8.6.8 South Africa
- 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

9.1. Recent Developments
9.2. Company Categorization
9.3. Supply Chain & Channel Partners (based on availability)
9.4. Market Share & Positioning Analysis (based on availability)
9.5. Vendor Landscape (based on availability)
9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL BLOOD PURIFICATION EQUIPMENT INDUSTRY

10.1. Top Companies Market Share Analysis
10.2. Company Profiles
- 10.2.1 CytoSorbents Corporation
- 10.2.2 Baxter International Inc
- 10.2.3 ExThera Medical Corporation
- 10.2.4 Aethlon Medical Inc
- 10.2.5 Fresenius SE & Co. KGaA
- 10.2.6 Cerus Corporation
- 10.2.7 Jafron Biomedical Co. Ltd
- 10.2.8 Spectra Medical Inc
- 10.2.9 B. Braun Melsungen AG
- 10.2.10 Nikkiso Co. Ltd